{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T20:05:24Z","timestamp":1783800324626,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["YDZX20223100001004"],"award-info":[{"award-number":["YDZX20223100001004"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3506700 & 2024YFC3506704"],"award-info":[{"award-number":["2024YFC3506700 & 2024YFC3506704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Administration of Traditional Chinese Medicine","award":["(ZXXT-202303)"],"award-info":[{"award-number":["(ZXXT-202303)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dragon\u2019s Blood, from the Dracaena cochinchinensis plant, is known for enhancing blood circulation. Its main components are Dragon\u2019s Blood phenolic extracts (DBE). To pinpoint the active DBE constituents that are effective against thrombosis and understand their mechanism of action, the PT-stroke model was employed to assess DBE\u2019s antithrombotic effects on cerebral blood flow and platelet aggregation. This investigation demonstrates that DBE enhances cerebral blood flow and inhibits ADP-induced platelet aggregation in photothrombotic (PT) stroke models. An FeCl3-induced carotid artery thrombosis model was developed to test the antithrombotic activity of four DBE fractions. Through screening with this model, the ethyl acetate (EA) and methanol fractions were identified as the principal active components that effectively reduced thrombus weight and improved hemodynamics. Furthermore, the EA fraction was found to preserve the integrity of the blood\u2013brain barrier. Phytochemical isolation allowed for the identification of compounds in the EA fractions, and UHPLC-MS was performed to characterize DBE and its active components in the bloodstream. In vitro ADP-induced platelet aggregation assays highlighted the active compounds. Through phytochemical analysis, Loureirin D (compound 17) was identified as a predominant constituent present in plasma. In vitro assays revealed that compounds 1 and 17 possess strong antiplatelet activity, with Loureirin D being confirmed as a selective P2Y12 receptor antagonist via molecular docking and cellular thermal shift assays. These findings substantiate Loureirin D as a pivotal antithrombotic component in DBE and its potential as a P2Y12-targeting therapeutic agent for thrombosis treatment.<\/jats:p>","DOI":"10.3390\/ijms27010282","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:28:19Z","timestamp":1766986099000},"page":"282","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioactivity-Guided Fractionation of Dragon\u2019s Blood Phenolic Extracts Reveals Loureirin D as a P2Y12 Inhibitor Mediating Antiplatelet Effects"],"prefix":"10.3390","volume":"27","author":[{"given":"Jiawen","family":"Peng","sequence":"first","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liao","sequence":"additional","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiange","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"},{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990\u20132019: An analysis for the Global Burden of Disease Study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9060143","DOI":"10.1155\/2016\/9060143","article-title":"Platelet Activation: The Mechanisms and Potential Biomarkers","volume":"2016","author":"Yun","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107684","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107684","article-title":"Factors associated with clopidogrel resistance and clinical outcomes in ischemic cerebrovascular disease: A retrospective study","volume":"33","author":"Wu","year":"2024","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106834","DOI":"10.1016\/j.bioorg.2023.106834","article-title":"11,12-seco-Abietane-type diterpene lactones with potential antiplatelet activity from Salvia prattii","volume":"140","author":"Xia","year":"2023","journal-title":"Bioorgan. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115197","DOI":"10.1016\/j.jep.2022.115197","article-title":"A network pharmacology-based study on the quality control markers of antithrombotic herbs: Using Salvia miltiorrhiza-Ligusticum chuanxiong as an example","volume":"292","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12038-019-9872-8","article-title":"Resina draconis inhibits the endoplasmic-reticulum-induced apoptosis of myocardial cells via regulating miR-423-3p\/ERK signaling pathway in a tree shrew myocardial ischemia\u2013reperfusion model","volume":"44","author":"Yang","year":"2019","journal-title":"J. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopha.2017.08.141","article-title":"Anti-atherosclerotic effect of Longxuetongluo Capsule in high cholesterol diet induced atherosclerosis model rats","volume":"97","author":"Zhou","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1021\/acs.jafc.2c01219","article-title":"Triad3A-Dependent TLR4 Ubiquitination and Degradation Contributes to the Anti-Inflammatory Effects of Pterostilbene on Vascular Dementia","volume":"70","author":"Xu","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhao, Y., Yang, A., Tian, Y., Pang, D., Sun, J., Tang, L., Huang, H., Wang, Y., and Zhao, Y. (2020). Chinese Dragon\u2019s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00669"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12967-021-02825-2","article-title":"Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: From bedside to bench","volume":"19","author":"Yang","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phymed.2013.08.007","article-title":"Dragon\u2019s blood dropping pills have protective effects on focal cerebral ischemia rats model","volume":"21","author":"Xin","year":"2013","journal-title":"Phytomedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112138","DOI":"10.1016\/j.jep.2019.112138","article-title":"Phenolic constituents, pharmacological activities, quality control, and metabolism of Dracaena species: A review","volume":"244","author":"Sun","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jare.2021.01.016","article-title":"Longxuetongluo Capsule protects against cerebral ischemia\/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms","volume":"33","author":"Pan","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"155993","DOI":"10.1016\/j.phymed.2024.155993","article-title":"Longxuetongluo Capsule alleviate ischemia\/reperfusion induced cardiomyocyte apoptosis through modulating oxidative stress and mitochondrial dysfunction","volume":"134","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.3390\/molecules190710650","article-title":"A Systematic Review of the Botanical, Phytochemical and Pharmacological Profile of Dracaena cochinchinensis, a Plant Source of the Ethnomedicine \u201cDragon\u2019s Blood\u201d","volume":"19","author":"Fan","year":"2014","journal-title":"Molecules"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103659","DOI":"10.1016\/j.bioorg.2020.103659","article-title":"Bioactive flavonoid dimers from Chinese dragon\u2019s blood, the red resin of Dracaena cochinchinensis","volume":"97","author":"Lang","year":"2020","journal-title":"Bioorgan. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jep.2014.01.032","article-title":"Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese dragon\u2019s blood","volume":"152","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4858201","DOI":"10.1155\/2020\/4858201","article-title":"Systems Pharmacology-Dissection of the Molecular Mechanisms of Dragon\u2019s Blood in Improving Ischemic Stroke Prognosis","volume":"2020","author":"Jiang","year":"2020","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jep.2011.03.063","article-title":"Dragon\u2019s Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities","volume":"135","author":"Xin","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jep.2010.11.008","article-title":"Comparison of the chemical profiles and anti-platelet aggregation effects of two \u201cDragon\u2019s Blood\u201d drugs used in traditional Chinese medicine","volume":"133","author":"Yi","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/jth.12035","article-title":"Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation","volume":"10","author":"Chang","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.me.30.020179.001003","article-title":"Secretable storage pools in platelets","volume":"30","author":"Holmsen","year":"1979","journal-title":"Annu. Rev. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V75.5.1081.1081","article-title":"Released Adenosine Diphosphate Stabilizes Thrombin-Induced Human Platelet Aggregates","volume":"75","author":"Cattaneo","year":"1990","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2006.01789.x","article-title":"P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1\/2 activation","volume":"4","author":"Shankar","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11239-017-1516-y","article-title":"PLATO Investigators, Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome","volume":"44","author":"Lowenstern","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","article-title":"A Comparative Study of Dual Versus Monoantiplatelet Therapy in Patients with Acute Large-Artery Atherosclerosis Stroke","volume":"23","author":"Yi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/jth.12952","article-title":"P2Y12 receptors: Structure and function","volume":"13","author":"Cattaneo","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/09537104.2011.597527","article-title":"The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75\u2009mg\/day clopidogrel may be overcome within 1 month of treatment","volume":"23","author":"Kalantzi","year":"2012","journal-title":"Platelets"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Morillas, A.G., Besson, V.C., and Lerouet, D. (2021). Microglia and Neuroinflammation: What Place for P2RY12?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041636"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bph.12435","article-title":"Platelet P2Y12 receptors are involved in the haemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng","volume":"171","author":"Gao","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0049-3848(99)00104-8","article-title":"Antithrombotic activities of green tea catechins and (\u2212)-epigallocatechin gallate","volume":"96","author":"Kang","year":"1999","journal-title":"Thromb. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0031-9422(02)00622-2","article-title":"Homoisoflavonoids and xanthones from the tubers of wild and in vitro regenerated Ledebouria graminifolia and cytotoxic activities of some of the homoisoflavonoids","volume":"62","author":"Mutanyatta","year":"2003","journal-title":"Phytochemistry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/1028602042000204126","article-title":"A new meta-homoisoflavane from the fresh stems of Dracaena cochinchinensis","volume":"8","author":"Zheng","year":"2006","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/S0968-0896(03)00233-5","article-title":"Structure\u2013activity relationships of antileishmanial and antimalarial chalcones","volume":"11","author":"Liu","year":"2003","journal-title":"Bioorgan. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhao, J.-W., Chen, D.-S., Deng, C.-S., Wang, Q., Zhu, W., and Lin, L. (2017). Evaluation of anti-inflammatory activity of compounds isolated from the rhizome of Ophiopogon japonicas. BMC Complement. Altern. Med., 17.","DOI":"10.1186\/s12906-016-1539-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1248\/cpb.35.3597","article-title":"Homoisoflavonoids and Related Compounds. IV. Absolute Configurations of Homoisoflavonoids from Caesalpinia sappan L.","volume":"35","author":"Namikoshi","year":"1987","journal-title":"Chem. Pharm. Bull."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/s-2002-34403","article-title":"Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri","volume":"68","author":"Likhitwitayawuid","year":"2002","journal-title":"Planta Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0031-9422(94)00738-F","article-title":"Flavonoids of dragon\u2019s blood from Dracaena cinnabari","volume":"38","author":"Masaoud","year":"1995","journal-title":"Phytochemistry"},{"key":"ref_41","first-page":"755","article-title":"Studies on the chemical constituents of chloroform extract of Dracaena cochinchinensis","volume":"33","author":"Lu","year":"1998","journal-title":"Acta Pharm. Sin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/np000085h","article-title":"Phenolic compounds of Dragon\u2019s blood from Dracaena draco","volume":"63","author":"Bermejo","year":"2000","journal-title":"J. Nat. Prod."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/ptr.5890","article-title":"In vitro Antitubercular Activity of 3-Deoxysappanchalcone Isolated From the Heartwood of Caesalpinia sappan Linn","volume":"31","author":"Seo","year":"2017","journal-title":"Phytother. Res."},{"key":"ref_44","first-page":"336","article-title":"Chemical constituents of Dragon\u2019s blood resin from Dracaena cochinchinensis in Yunnan and their antifungal activity","volume":"17","author":"Wang","year":"1995","journal-title":"Acta Bot. Yunnanica"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Prommee, N., Itharat, A., Thongdeeying, P., Makchuchit, S., Pipatrattanaseree, W., Tasanarong, A., Ooraikul, B., and Davies, N.M. (2022). Exploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds. BMC Complement. Med. Ther., 22.","DOI":"10.1186\/s12906-022-03678-y"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1021\/np50060a013","article-title":"Retrodihydrochalcones from Dracaena loureiri","volume":"51","author":"Meksuriyen","year":"1988","journal-title":"J. Nat. Prod."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dutra-Behrens, M., and Schmeda-Hirschmann, G. (2016). New Homoisoflavanes, a New Alkaloid and Spirostane Steroids from the Roots of Herreria montevidensis Klotzsch ex Griseb. (Herreriaceae). Molecules, 21.","DOI":"10.3390\/molecules21111589"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1071\/CH9711257","article-title":"Colouring matters of Australian plants. XVI. Minor constituents of Dianella revoluta and Stypandra grandis","volume":"24","author":"Cooke","year":"1971","journal-title":"Aust. J. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phytol.2013.12.003","article-title":"Isopimarane diterpenes and flavan derivatives from the twigs of Caesalpinia furfuracea","volume":"7","author":"Siridechakorn","year":"2014","journal-title":"Phytochem. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hlca.200890007","article-title":"Stilbene Derivatives from Gnetum montanum Markgr. f. megalocarpum Markgr","volume":"91","author":"Wang","year":"2008","journal-title":"Helv. Chim. Acta"},{"key":"ref_51","first-page":"1249","article-title":"Evaluation of chemical constituents of Draconis Sanguis and its protective effect on renal tubular injury in diabetic kidney disease","volume":"49","author":"Zhou","year":"2024","journal-title":"China J. Chin. Mater. Medica"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/np5002576","article-title":"Antifungal Activity of Resveratrol Derivatives against Candida Species","volume":"77","author":"Papon","year":"2014","journal-title":"J. Nat. Prod."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1073\/pnas.1905309116","article-title":"Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke","volume":"116","author":"Rust","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108913","DOI":"10.1016\/j.intimp.2022.108913","article-title":"Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3\/NF-\u03baB and inflammasome activation","volume":"108","author":"Ding","year":"2022","journal-title":"Int. Immunopharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/282\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T05:14:41Z","timestamp":1767244481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010282"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010282","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}